Filing Details
- Accession Number:
- 0001325812-14-000046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-19 16:38:49
- Reporting Period:
- 2014-06-17
- Filing Date:
- 2014-06-19
- Accepted Time:
- 2014-06-19 16:38:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1458494 | Akshay Vaishnaw | 300 Third Street Cambridge MA 02142 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-17 | 1,875 | $9.14 | 1,875 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-06-17 | 2,500 | $7.10 | 4,375 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-06-17 | 6,250 | $9.30 | 10,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-17 | 2,498 | $69.33 | 8,127 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-17 | 8,127 | $69.97 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-17 | 2,500 | $0.00 | 2,500 | $7.10 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-17 | 1,875 | $0.00 | 1,875 | $9.14 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-17 | 6,250 | $0.00 | 6,250 | $9.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2021-11-30 | No | 4 | M | Direct | |
| 3,750 | 2020-12-08 | No | 4 | M | Direct | |
| 25,001 | 2021-06-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 35 | Indirect | by Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2013.
- Sale prices ranged from $68.71 to $69.705.
- Sale prices ranged from $69.71 to $70.30.
- The reporting person owns 35 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Billionaire Hedge Funds
